Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

SCS Pipeline Products Market Overview

An SCS is a device that comprises a surgically-implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders. The SCS pipeline market research report provides comprehensive information about the SCS pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       Canada

Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       NMPA

·       TGA

·       UKCA

·       De Novo

Leading Companies ·       Beijing Leading Medical Valley Technology Development Co Ltd

·       Beijing Lingchuang Yigu Technology Development Co Ltd

·       Boston Scientific Corp

·       Cerevast Therapeutics Inc

·       Direct Spinal Therapeutics, Inc.

·       Duke University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

SCS Pipeline Market Segmentation by Territories

Some of the key territories in the SCS market are the US, Europe, China, Australia, and Canada among others. As of May 2023, the US has the highest number of pipeline products.

SCS Pipeline Market Analysis, by Territories, 2023 (%)

SCS Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the SCS pipeline market, download a free report sample

SCS Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the SCS pipeline market are PMA, 510(k), CE, NMPA, TGA, UKCA, and De Novo among others. As of May 2023, PMA is the most followed pathway for pipeline products.

SCS Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

SCS Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the SCS pipeline market, download a free report sample

SCS Pipeline Market – Competitive Landscape

Some of the key companies in the SCS pipeline market are Beijing Leading Medical Valley Technology Development Co Ltd, Beijing Lingchuang Yigu Technology Development Co Ltd, Boston Scientific Corp, Cerevast Therapeutics Inc, Direct Spinal Therapeutics, Inc., and Duke University among others.

Beijing Leading Medical Valley Technology Development Co Ltd: Beijing Leading Medical Valley Technology Development Co Ltd (Medical Valley Technology) is a medical device company that is engaged in developing technologies for implantable neuroelectric stimulation to treat neurological functioning disorders. Medical Valley Technology is headquartered in Beijing, China.

Segments Covered in the Report

SCS Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • Canada

SCS Pipeline Market Regulatory Paths Outlook

  • PMA
  • 510(k)
  • CE
  • NMPA
  • TGA
  • UKCA
  • De Novo

Scope

  • Extensive coverage of the SCS under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of SCS and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of SCS under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Beijing Leading Medical Valley Technology Development Co Ltd
Beijing Lingchuang Yigu Technology Development Co Ltd
Boston Scientific Corp
Cerevast Therapeutics Inc
Direct Spinal Therapeutics, Inc.
Duke University
Hangzhou Shenluo Medical Technology Co Ltd
Imperial College London
Lawson Health Research Institute
Meagan Medical Inc.
Medtronic Inc
Medtronic Plc
Micro-Leads Inc
MicroTransponder Inc
Neuronoff Inc
NeuroOne Medical Technologies Corp
Nevro Corp
Nexstim Plc
Nuvectra Corp (Inactive)
Onward Medical NV
Onward Technologies Ltd
Quantum Nanostim LLC
Reach Neuro Inc
Rowan University
Saluda Medical Pty Ltd
Soin Neuroscience Inc
Soterix Medical Inc
SpineX
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stimdia Medical Inc
SynerFuse Inc
University of California Los Angeles
University of Cambridge
University of Minnesota
Wavegate Corp
WISE s.r.l.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Spinal Cord Stimulators (SCS) Overview

  • 3 Products under Development

    • 3.1 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development
    • 3.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Territory
    • 3.3 Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path
    • 3.4 Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date
    • 3.5 Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials

  • 4 Spinal Cord Stimulators (SCS) – Pipeline Products under Development by Companies

    • 4.1 Spinal Cord Stimulators (SCS) Companies – Pipeline Products by Stage of Development
    • 4.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development

  • 5 Spinal Cord Stimulators (SCS) Companies and Product Overview

    • 5.1 Beijing Leading Medical Valley Technology Development Co Ltd Company Overview

      • 5.1.1 Beijing Leading Medical Valley Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Beijing Lingchuang Yigu Technology Development Co Ltd Company Overview

      • 5.2.1 Beijing Lingchuang Yigu Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Boston Scientific Corp Company Overview

      • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Cerevast Therapeutics Inc Company Overview

      • 5.4.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Direct Spinal Therapeutics, Inc. Company Overview

      • 5.5.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Duke University Company Overview

      • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Hangzhou Shenluo Medical Technology Co Ltd Company Overview

      • 5.7.1 Hangzhou Shenluo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Imperial College London Company Overview

      • 5.8.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Lawson Health Research Institute Company Overview

      • 5.9.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Meagan Medical Inc. Company Overview

      • 5.10.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Medtronic Inc Company Overview

      • 5.11.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Medtronic Plc Company Overview

      • 5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Micro-Leads Inc Company Overview

      • 5.13.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 MicroTransponder Inc Company Overview

      • 5.14.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Neuronoff Inc Company Overview

      • 5.15.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 NeuroOne Medical Technologies Corp Company Overview

      • 5.16.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Nevro Corp Company Overview

      • 5.17.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Nexstim Plc Company Overview

      • 5.18.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Nuvectra Corp (Inactive) Company Overview

      • 5.19.1 Nuvectra Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Onward Medical NV Company Overview

      • 5.20.1 Onward Medical NV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Onward Technologies Ltd Company Overview

      • 5.21.1 Onward Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Quantum Nanostim LLC Company Overview

      • 5.22.1 Quantum Nanostim LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Reach Neuro Inc Company Overview

      • 5.23.1 Reach Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Rowan University Company Overview

      • 5.24.1 Rowan University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Saluda Medical Pty Ltd Company Overview

      • 5.25.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Soin Neuroscience Inc Company Overview

      • 5.26.1 Soin Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Soterix Medical Inc Company Overview

      • 5.27.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 SpineX Company Overview

      • 5.28.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.29.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 St. Jude Medical LLC Company Overview

      • 5.30.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 Stimdia Medical Inc Company Overview

      • 5.31.1 Stimdia Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 SynerFuse Inc Company Overview

      • 5.32.1 SynerFuse Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.33 University of California Los Angeles Company Overview

      • 5.33.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.34 University of Cambridge Company Overview

      • 5.34.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview

    • 5.35 University of Minnesota Company Overview

      • 5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

    • 5.36 Wavegate Corp Company Overview

      • 5.36.1 Wavegate Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.37 WISE s.r.l. Company Overview

      • 5.37.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Spinal Cord Stimulators (SCS)- Recent Developments
  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Frequently asked questions

Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.